{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fcannaweek.simplecast.com%2Fepisodes%2Fep23-KbjTkzc_","width":444,"version":"1.0","type":"rich","title":"European Hemp and CBD in Peril (Lorenza Romanese) ","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/48a66388-4201-45bf-92c7-3c5aaf8cee6d/81974fd4-3081-4914-a959-9817409d46cb/cannaweek-logo-w-tag-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/299483d2-3221-4bd0-8eae-1e3da083d1cf\" height=\"200\" width=\"100%\" title=\"European Hemp and CBD in Peril (Lorenza Romanese) \" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"A  conversation with Lorenza Romanese, Managing Director at European Industrial Hemp Association  and CKO of New Frontier Data, John Kagia. They discuss the potential impact of the European Commission's attempted rescheduling of CBD to a narcotic. "}